Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948

被引:62
作者
Smith, Ruben [1 ,2 ,3 ]
Scholl, Michael [1 ,4 ,5 ,6 ]
Leuzy, Antoine [1 ,4 ,5 ]
Jogi, Jonas [7 ]
Ohlsson, Tomas [8 ]
Strandberg, Olof [1 ]
Hansson, Oskar [1 ,9 ]
机构
[1] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Malmo, Sweden
[2] Skane Univ Hosp, Dept Neurol, Lund, Sweden
[3] Skane Univ Hosp, Dept Neurol, SE-20502 Malmo, Sweden
[4] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden
[5] Univ Gothenburg, Dept Psychiat & Neurochem, Gothenburg, Sweden
[6] UCL, Dementia Res Ctr, Dept Neurodegenerat Dis, Inst Neurol, Queen Sq, London, England
[7] Skane Univ Hosp, Dept Clin Physiol & Nucl Med, Lund, Sweden
[8] Skane Univ Hosp, Dept Radiat Phys, Lund, Sweden
[9] Skane Univ Hosp, Memory Clin, SE-20502 Malmo, Sweden
关键词
Tau; PET; Neurodegeneration; Alzheimer's disease; Head-to-head; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PET TRACER; F-18-AV-1451; BINDING; DIAGNOSTIC-CRITERIA; PATHOLOGY; QUANTIFICATION; TISSUE; BRAIN; T807;
D O I
10.1007/s00259-019-04496-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose [F-18]flortaucipir binds to paired helical filament tau and accurately identifies tau in Alzheimer's disease (AD). However, "off-target" binding interferes with the quantification of [F-18]flortaucipir in several brain regions. Recently, other tau PET tracers have been developed. Here, we compare [F-18]flortaucipir with the novel tau tracer [F-18]RO948 head-to-head in vivo. Methods We included 18 participants with AD, three with amyloid-beta-positive amnestic mild cognitive impairment, and four healthy controls. All underwent [F-18]flortaucipir (80-100 min) and [F-18]RO948 (70-90) PET scans within approximately 1 month. Four study participants underwent 0-100-min dynamic scanning. Standardized uptake value ratios (SUVRs) were created using an inferior cerebellar reference region. Results Neocortical tracer retention was highly comparable using both SUVR and distribution volume ratio-1 values obtained from dynamic scans. However, [F-18]RO948 retention was significantly higher in the entorhinal cortex and lower in the basal ganglia, thalamus, and choroid plexus compared with [F-18]flortaucipir. Increased off-target binding was observed with age for both tracers. Several cases exhibited strong [F-18]RO948 retention in the skull/meninges. This extra-cerebral signal, however, did not affect diagnostic accuracy and remained relatively unchanged when re-examining a subsample after 1 year. Kinetic modeling showed an increase in [F-18]flortaucipir SUVR over the scanning interval, compared with a plateau for [F-18]RO948. Conclusion [F-18]RO948 and [F-18]flortaucipir bound comparably in neocortical regions, but [F-18]RO948 showed higher retention in the medial temporal lobe and lower intracerebral "off-target" binding. Time-dependent bias of SUVR estimates may prove less of a factor with [F-18]RO948, compared with previous tau ligands.
引用
收藏
页码:342 / 354
页数:13
相关论文
共 50 条
[1]   The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [J].
Albert, Marilyn S. ;
DeKosky, Steven T. ;
Dickson, Dennis ;
Dubois, Bruno ;
Feldman, Howard H. ;
Fox, Nick C. ;
Gamst, Anthony ;
Holtzman, David M. ;
Jagust, William J. ;
Petersen, Ronald C. ;
Snyder, Peter J. ;
Carrillo, Maria C. ;
Thies, Bill ;
Phelps, Creighton H. .
ALZHEIMERS & DEMENTIA, 2011, 7 (03) :270-279
[2]  
American Psychiatric Association, 2013, Diagnostic and Statistical Manual of Mental Disorders: DSM-5, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]
[3]  
[Anonymous], [No title captured]
[4]  
[Anonymous], [No title captured]
[5]   Criteria for the diagnosis of corticobasal degeneration [J].
Armstrong, Melissa J. ;
Litvan, Irene ;
Lang, Anthony E. ;
Bak, Thomas H. ;
Bhatia, Kailash P. ;
Borroni, Barbara ;
Boxer, Adam L. ;
Dickson, Dennis W. ;
Grossman, Murray ;
Hallett, Mark ;
Josephs, Keith A. ;
Kertesz, Andrew ;
Lee, Suzee E. ;
Miller, Bruce L. ;
Reich, Stephen G. ;
Riley, David E. ;
Tolosa, Eduardo ;
Troester, Alexander I. ;
Vidailhet, Marie ;
Weiner, William J. .
NEUROLOGY, 2013, 80 (05) :496-503
[6]  
Baker SL, 2017, DATA BRIEF, V15, P648, DOI 10.1016/j.dib.2017.10.024
[7]   Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging [J].
Baker, Suzanne L. ;
Lockhart, Samuel N. ;
Price, Julie C. ;
He, Mark ;
Huesman, Ronald H. ;
Schonhaut, Daniel ;
Faria, Jamie ;
Rabinovici, Gil ;
Jagust, William J. .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (02) :332-338
[8]   Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects [J].
Barret, Olivier ;
Alagille, David ;
Sanabria, Sandra ;
Comley, Robert A. ;
Weimer, Robby M. ;
Borroni, Edilio ;
Mintun, Mark ;
Seneca, Nicholas ;
Papin, Caroline ;
Morley, Thomas ;
Marek, Ken ;
Seibyl, John P. ;
Tamagnan, Gilles D. ;
Jennings, Danna .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (07) :1124-1131
[9]   In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand 18F-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls [J].
Betthauser, Tobey J. ;
Cody, Karly A. ;
Zammit, Matthew D. ;
Murali, Dhanabalan ;
Converse, Alexander K. ;
Barnhart, Todd E. ;
Stone, Charles K. ;
Rowley, Howard A. ;
Johnson, Sterling C. ;
Christian, Bradley T. .
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (01) :93-99
[10]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259